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ABSTRACT Bordetella pertussis is the causative agent of whooping cough, a serious
respiratory illness affecting children and adults, associated with prolonged cough
and potential mortality. Whooping cough has reemerged in recent years, emphasiz-
ing a need for increased knowledge of basic mechanisms of B. pertussis growth and
pathogenicity. While previous studies have provided insight into in vitro gene essen-
tiality of this organism, very little is known about in vivo gene essentiality, a critical
gap in knowledge, since B. pertussis has no previously identified environmental res-
ervoir and is isolated from human respiratory tract samples. We hypothesize that the
metabolic capabilities of B. pertussis are especially tailored to the respiratory tract
and that many of the genes involved in B. pertussis metabolism would be required
to establish infection in vivo. In this study, we generated a diverse library of trans-
poson mutants and then used it to probe gene essentiality in vivo in a murine
model of infection. Using the CON-ARTIST pipeline, 117 genes were identified as
conditionally essential at 1 day postinfection, and 169 genes were identified as con-
ditionally essential at 3 days postinfection. Most of the identified genes were associ-
ated with metabolism, and we utilized two existing genome-scale metabolic network
reconstructions to probe the effects of individual essential genes on biomass synthe-
sis. This analysis suggested a critical role for glucose metabolism and lipooligosac-
charide biosynthesis in vivo. This is the first genome-wide evaluation of in vivo gene
essentiality in B. pertussis and provides tools for future exploration.
IMPORTANCE Our study describes the first in vivo transposon sequencing (Tn-seq)
analysis of B. pertussis and identifies genes predicted to be essential for in vivo
growth in a murine model of intranasal infection, generating key resources for fu-
ture investigations into B. pertussis pathogenesis and vaccine design.
KEYWORDS Bordetella, Bordetella pertussis, Tn-seq, gene essentiality, in vivo,
metabolism
Whooping cough, caused by the Gram-negative bacterium Bordetella pertussis, is aserious respiratory illness in children and adults that can be fatal (1). Despite
widespread vaccination, whooping cough has reemerged in recent years, reinvigorat-
ing research into B. pertussis pathogenesis and vaccine design (2). Humans are the only
natural host for B. pertussis, but animal models, including baboons and mice (3–6), have
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been developed to facilitate study. Compared with other Bordetellae, the B. pertussis
genome is smaller with more pseudogenes (9.4% of the genome) and substantial
rearrangements mediated by insertion elements (7). This restricted genetic content is
thought to be a result of adaptation to the human host (7); however, the genetic
elements and changes that facilitate host specificity have not been identified.
Some insight into B. pertussis-host interaction has been gained by single gene
mutations and transposon mutagenesis in vitro (8–10). Select mutants with altered
virulence phenotypes in vitro have subsequently been evaluated for the effect of
mutation on B. pertussis survival in vivo, identifying virulence genes important for
infection (11, 12). More recently, high-throughput transposon sequencing (Tn-seq) has
been used to identify genes essential for in vitro growth of B. pertussis (13). Unlike
traditional transposon mutagenesis, which is based on the isolation of individual
mutant clones in a transposon library, Tn-seq is based on sequencing of a pool of
clones as a community. Because all members of the population are competing for the
same limited nutrients, metabolism-associated genes are most often identified by
Tn-seq, and Fyson et al. utilized Tn-seq to validate a computational model of B. pertussis
metabolism in vitro (13).
Because metabolism-associated genes are central to host-pathogen specificity, we
used Tn-seq to probe in vivo gene essentiality in B. pertussis. We generated a trans-
poson library with high insertion coverage and measured growth in vitro and in vivo
using an intranasal model of murine infection. These studies reveal novel observations
about B. pertussis metabolism, gene regulation, and metabolism-associated virulence
factors in vitro and within the host environment.
RESULTS
Construction and validation of Tn library. The B. pertussis library was constructed
through introduction of the pSAM-Km transposon (14) into B. pertussis strain UT25-lux
(as described in Text S1 in the supplemental material) by conjugation with an Esche-
richia coli diaminopimelic acid (DAP) auxotrophic donor strain (15). The library contains
approximately 3.0 106 clones, determined by enumeration of CFU of the library
before harvest from BG plates. High-throughput sequencing on the Illumina Hi-Seq
platform revealed that 73.6% of the possible insertion sites (based on the TA insertion
site sequence for mariner transposons) and 88.5% of genes were occupied by inser-
tions, which is representative of a highly complex library. Figure 1 shows the distribu-
tion of insertions throughout the genome (16). The high insertion coverage occurred
despite high GC content of the genome (7, 17).
High- and low-density libraries can be distinguished by the separation between
peaks on a histogram plotting the percentage of potential insertion sites occupied per
gene (Fig. 2A); a more-dense library is characterized by a distinct and greater magni-
tude difference between peaks (18). The greatest number of genes with a low percent-
age of TA site occupation is considered the essential gene peak, and the genes with the
highest percentage of TA site occupation form the second, nonessential peak. As
demonstrated in Fig. 2A, there is a clear separation between the two peaks, which is
consistent with a well-saturated library.
Tn-seq data (from samples grown in vitro on BG agar) were analyzed using two
analysis programs, TRANSIT (19) and ARTIST (20), that both utilize a hidden Markov
model (HMM). In Tn-seq analysis, HMMs identify the most probable essentiality state of
a region by assessing a sequence of TA sites and incorporating information from
neighboring TA sites in order to improve the accuracy of the essentiality determination
(21). These programs classify genes as essential based on the essentiality classification
of regions within a gene. Classification of a gene as essential presumes that gene loss
is associated with an impairment of growth that can be inferred by the number of
transposon insertions present in that gene. Using these two HMM-based methods, we
generated a list of 609 genes (Fig. 2B; see also Table S2 in the supplemental material)
that were classified as essential by both programs and are required for efficient in vitro
growth (Text S1).
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We further analyzed the set of genes classified as essential by both TRANSIT and
ARTIST, presuming that genes within this combined set were more likely than either set
individually to represent genes that are truly essential in vitro. Identification of multiple
essential genes within the same metabolic pathway would suggest the importance of
that pathway for B. pertussis metabolism and viability. To organize the data, we
manually added KEGG pathway classifications to 499 essential genes, which for many
FIG 1 B. pertussis transposon library. A map of insertions (red) and their distribution across the genome was
generated by CGView (16). Coding regions of genes (coding sequences [CDS]) are shown in blue and
separated by strand. Locations of tRNA and rRNA are shown in purple and green, respectively. GC content
is represented in black.
FIG 2 Analysis of in vitro gene essentiality using TRANSIT and ARTIST. (A) Histogram showing the TA site insertion saturation
per gene. (B) A Venn diagram of genes identified as essential by ARTIST (red) and TRANSIT (blue). A total of 609 genes were
identified by both analysis pipelines (purple).
In Vivo Tn-seq in B. pertussis
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genes resulted in more than one annotation per gene (Table S3). The remaining 110
essential genes lacked an identified pathway classification. Mapping to KEGG pathways
revealed information about essential metabolic pathways under our growth conditions
(Table S3 and Fig. S1). The most represented categories were biosynthesis of secondary
metabolites, biosynthesis of antibiotics, ribosome, microbial metabolism in diverse
environments, biosynthesis of amino acids, and metabolism of cofactors and vitamins.
Multiple genes within the gluconeogenesis and pentose phosphate pathways were
classified as essential (Fig. 3), supporting prior findings that these pathways are present
and functional in B. pertussis (7). Originally, the tricarboxylic acid (TCA) cycle in B.
pertussis was considered nonfunctional despite the observation that the genome
contains all required genes (7, 22). Recently, the enzymatic activities thought to be
absent (citrate synthase, aconitase, and isocitrate dehydrogenase) in B. pertussis were
shown to be present (23). In support of these findings, our data indicated that genes
encoding citrate synthase and isocitrate dehydrogenase are essential in vitro in our
screen, as well as the majority (all but two) of the remaining genes assigned to reactions
within the tricarboxylic acid cycle (Fig. 3). The two nonessential genes (BP2014 and
BP2021) are annotated as aconitate hydratases (responsible for interconversion of
citrate and isocitrate), and these genes may be functionally redundant. Together, these
data suggest not only a functional TCA cycle but that the TCA cycle is critical for growth
under our in vitro growth conditions on BG agar.
Unexpectedly, the Bvg two-component system (bvgAS) was computationally classi-
fied as essential for in vitro growth by our analysis by TRANSIT and ARTIST. However,
bvgAS did tolerate a small number of insertions (three insertions in bvgS and one
insertion in bvgA, all at distinct TA sites) and is not identified as essential by stringent
analysis (24). BvgAS has been characterized in many strains of Bordetellae, including
strains of B. pertussis, and these strains are able to tolerate mutations within the bvgAS
genes, suggesting that it is not truly essential for in vitro growth. To confirm that bvgAS
could be deleted in the strain used for this study, we generated B. pertussis UT25
ΔbvgAS. This strain grows under the conditions that the library was generated (static
FIG 3 Carbon metabolism in B. pertussis. Pathways with all or many genes identified as essential for in
vitro growth are shown in green. Genes involved in the interconversion of glucose-1P and fructose-6P
were classified as conditionally essential in vivo, and this reaction is shown in red.
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growth on BG agar at 37°C), suggesting that bvgAS are not true essential genes. One
explanation is that lacking BvgAS was disadvantageous for growth under our condi-
tions. We tested the hypothesis by comparing the growth of B. pertussis UT25 ΔbvgAS
to the growth of wild-type B. pertussis UT25 under both modulating (active BvgAS) and
nonmodulating (inactive BvgAS) conditions. B. pertussis UT25 exhibited a growth defect
when BvgAS was inactive, either genetically or through chemical modulation with
MgSO4 (Fig. 4), supporting the hypothesis that lacking bvgAS was disadvantageous for
growth. It is important to note that these growth studies were performed in Stainer-
Scholte medium, a standard, defined liquid growth medium for B. pertussis, rather than
on BG agar, which was used to generate the library. Demonstration of a BvgAS-
dependent growth defect provides a potential explanation for identification of bvgAS
as essential in our screen, but other explanations for this observation exist, highlighting
the limitations of Tn-seq analysis for determining gene essentiality.
Conditional essentiality in vivo. To determine which genes contribute to infection,
CD1 mice were intranasally infected with approximately 5 106 CFU of the library
cultivated on BG agar. The mice were euthanized at either day 1 or day 3 postinfection,
and B. pertussis conditional gene essentiality was determined at each of these time
points. The average bacterial burden in combined lung and trachea samples at day 1
was 7.4 105 CFU/organ, and at day 3, it was 1.2 107 CFU/organ (Fig. 5), consistent
with published work using this strain of mouse and a similar inoculum (25). The entire
organ homogenate was plated on BG agar, and then bacterial colonies were harvested
FIG 4 Growth curve of BvgAS-active and BvgAS-inactive B. pertussis UT25. Wild-type (black) andobvgAS
B. pertussis UT25 (pink) were grown in SSM as described in Materials and Methods. To modulate wild-type
B. pertussis UT25 to a BvgAS-inactive state, 40 mM MgSO4 was added to all passages in SSM (blue).
Bacterial growth was determined by the optical density at 600 nm (OD600).
FIG 5 Bacterial burden in organs of B. pertussis-infected mice. The lungs and trachea of infected mice
were removed and homogenized at the indicated time point, and the homogenates were diluted and
plated, and the bacteria were enumerated to determine CFU/organ. Each point represents the total
bacteria enumerated from the combined lung and trachea from one animal (n 11 at day 1 and n 12
at day 3). The means  standard deviations (error bars) are shown.
In Vivo Tn-seq in B. pertussis
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after 3 days of growth, genomic DNA was isolated, and samples were prepared for
high-throughput sequencing by Illumina HiSeq platform.
We used ARTIST (20) for in vitro to in vivo comparisons, which utilizes simulation-
based normalization followed by initial analysis by Mann-Whitney U tests and further
refinement using a hidden Markov model. Genes that are classified as essential for in
vitro growth are excluded from in vivo analysis, as clones with insertions in these genes
are absent from our library. The ARTIST pipeline includes analysis to determine whether
a bottleneck is present under the experimental conditions that could influence essen-
tiality classifications despite normalization. When the bottleneck simulation was run on
our in vitro data using parameters from our in vivo experimental conditions, the
false-positive rates calculated for each of the three input samples were 2.9, 5.3, and
4.0% with standard deviations of 0.08, 0.12, and 0.08%, respectively. This result indi-
cates an estimated false-positive rate of about 4% for each individual in vivo sample. In
order to reduce the chance that we would falsely designate a gene as essential, we
utilized the following consensus method. After ARTIST computationally classified each
individual in vivo sample by comparison to the respective in vitro sample, we examined
the ARTIST-derived gene essentiality for each of the 11 or 12 replicates of each gene at
each time point (Table S4). If a replicate was classified as essential, the gene associated
with that replicate would earn a point. The sum of the replicate points was the
consensus score. We designated a gene as essential based on the consensus score. As
anticipated, increasing the stringency, by requiring a greater consensus score in order
to designate a gene as essential, resulted in designation of a smaller number of genes
as conditionally essential (Fig. S2). We designated a gene as conditionally essential if
50% of the replicates (a score of 6) for that gene were computationally classified as
essential as previously described (20). Thus, genes designated as essential by this
consensus method reduce false-positive essentiality designations attributable to the
effect of the bottleneck on computational gene classification (20).
We chose to perform these analyses at both day 1 and day 3 postinfection to
determine whether gene essentiality differed as infection progressed. Three days
postinfection is at or near the peak of bacterial burden (25). We hypothesized that the
number of essential genes would increase at day 3 compared to day 1 as the bacterial
population continued to be exposed to selection pressure. We identified 117 genes as
conditionally essential at day 1 postinfection and 169 genes as conditionally essential
at day 3 postinfection, with 94 genes shared between the two time points (Fig. 6 and
Table S5). When all the genes identified at either day 1 or day 3 postinfection are
included, 192 genes are identified as conditionally essential (Table S5).
B. pertussis in vivo metabolism. Very few prototypical virulence factors were
identified, and this was anticipated based on the methodology of Tn-seq. Clones in the
library with mutations of genes encoding secreted factors (for example, cyaA encoding
adenylate cyclase toxin and ptxA encoding pertussis toxin) are complemented by other
library clones within the population and are not identified in this screen. B. pertussis
carries genes encoding an arsenal of adhesins, including Fim2, Fim3, and filamentous
hemagglutinin that are included in the acellular vaccine, and not identifying these
FIG 6 B. pertussis genes that are conditionally essential in vivo. CON-ARTIST was used for this analysis;
117 essential genes identified at 1 day postinfection are shown in yellow, and 169 genes identified as
essential at 3 days postinfection are shown in gray.
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factors is expected, as their functions may be redundant in our model of infection. A
recent study utilized RNA-seq to characterize the BvgAS regulon, including describing
metabolic genes under BvgAS control (26). BvgAS is well characterized for its role in
regulation of B. pertussis virulence, and we hypothesized that some metabolic genes
identified as essential in our in vivo model would be under BvgAS control because of
their importance in adaptation to the host nutritional environment. Because BvgAS-
activated genes and Bvg-repressed genes have been shown to be expressed during B.
pertussis infection in murine models (27), we compared our in vivo essential list with
known BvgAS-activated and BvgAS-repressed genes (26). Out of the 192 genes iden-
tified at day 1 or day 3 postinfection, 7 were positively regulated by BvgAS, and 22 were
negatively regulated by BvgAS (Table 1). Most of these 29 genes are associated with
metabolism, suggesting a role for BvgAS in coordination of B. pertussis metabolism in
vivo.
The majority of genes required for infection had metabolic functions. Out of the
total 192 genes designated as conditionally essential in vivo, 117 had one or more KEGG
pathway classifications (Table S5 and Fig. S1). Genes associated with transport, biosyn-
thesis of secondary metabolites, and biosynthesis of antibiotics were enriched in our
analysis (Table S5 and Fig. S1). Twenty-eight genes annotated as transporters were
conditionally essential in vivo (Table S5). The specificity of the majority of these
transporters is not yet known. We identified BP3494, encoding the BrkA autotrans-
porter, as conditionally essential in vivo. B. pertussis strains lacking brkA are more
sensitive to serum in vitro and are less virulent in mice (28–30), and our results are
consistent with these previous observations. Another autotransporter, the vaccine
component pertactin, was not identified, possibly due to the redundancy of autotrans-
porter function. Genes within the bhu operon (BP0344-BP0346), encoding a heme iron
TABLE 1 BvgAS regulation of conditionally essential genes in vivo
Gene category and
locus tag/gene name Annotation
BvgAS-activated genes
BP0790/ilvH Acetolactate synthase 3 regulatory subunit
BP1127
BP2930/cyoD Cytochrome 0 ubiquinol oxidase
BP2932/cyoB Ubiquinol oxidase subunit I
BP2934 Two-component system response regulator
BP2935 Two-component system, histidine kinase
BP3494/brkA Serum resistance protein
BvgAS-repressed genes
BP0250 Hypothetical protein
BP0618/lpdA_1 Dihydrolipoamide dehydrogenase
BP0619 Branched-chain amino acid ABC transporter ATP-binding protein
BP0670 Acyl-CoA dehydrogenase
BP0671 Hypothetical protein
BP0682 Putative exported protein
BP0683 4,5-Dihydroxyphthalate decarboxylase
BP0684A 2Fe-2S ferredoxin
BP0808 Hypothetical protein
BP1631/wcbA Capsular polysaccharide export protein
BP1818/dadA_1 D-Amino acid dehydrogenase small subunit
BP2368/prpC 2-Methylcitrate synthase
BP2644 Glycerol-3-phosphate dehydrogenase
BP3228/minD Septum site-determining protein
BP3575 Hypothetical protein
BP3671 Glycosyltransferase family protein
BP3672 Hypothetical protein
BP3679 TetR family transcriptional regulator
BP3740/colII Cytochrome c oxidase subunit II
BP3743/ctaD Cytochrome c oxidase polypeptide I
BP3744 Cytochrome c oxidase subunit II
BP3831 Amino acid ABC transporter substrate-binding protein
In Vivo Tn-seq in B. pertussis
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acquisition system (31), were essential at day 3 but not day 1, consistent with previous
literature that suggested that heme becomes more available to B. pertussis later in
infection perhaps through B. pertussis-mediated host damage (32).
Genes encoding a quinol oxidase (cyoABCD) were conditionally essential in vivo.
Similarly, these genes were identified in an in vivo transposon mutagenesis screen in P.
aeruginosa (14). Identification of this complex as important in two very different models
of infection with two distinct pathogens may highlight a role of the Cyo terminal
oxidase in aerobic respiration in vivo, potentially in adaptation to lower oxygen
concentrations within the host (33).
In silico analysis of Tn-seq data. Most of the genes identified in our in vivo analysis
were involved in metabolic functions, based on current annotation and homology, and
we used computational tools to obtain a more complete understanding of each gene’s
role in B. pertussis growth. Genome-scale metabolic network reconstructions (GENREs)
are computational representations of all the information known about the metabolism
of an organism, generated from literature and from genomic, proteomic, and transcrip-
tomic data sets. By mathematically representing the known metabolic genes, enzymes,
metabolites, and reactions involved in carrying out the chemical processes in a net-
work, it is possible to relate the genotype and phenotype. Through the use of
constraint-based analyses (34, 35), computational predictions of the organism’s meta-
bolic capabilities, including the impact of gene knockouts and of varied medium
conditions on growth, allow generation of novel hypotheses.
Two genome-scale metabolic network reconstructions have been recently pub-
lished for B. pertussis (13, 36), and these models were used as the basis for our
calculations. For any model, input nutrients must be defined for simulating biomass
production, and we chose components and stoichiometry based on existing defined
medium formulations. Biomass production was simulated using each model with an
array of nutrient inputs, including unrestricted nutrient availability, two different pub-
lished formulations of SSM (36, 37), and sputum media (SCFM) (38). BG medium is not
defined and cannot be used as an input for modeling biomass production. SSM
medium formulations are defined, but they were not originally designed with the goal
of simulating the in vivo environment and likely are not representative of nutrient
availability within the host. SCFM was developed as a chemically defined medium to
approximate nutrients available in the respiratory tracts of humans with cystic fibrosis
(CF). Although the nutrient composition of CF sputum is different than that of patients
affected by pertussis, SCFM is a suitable medium for application to the GENRE and may
better represent growth conditions for B. pertussis in the respiratory tract.
The Fyson et al. GENRE (13) and the Branco dos Santos et al. GENRE (36) each
generated biomass when grown in silico on SCFM media and when provided with
unrestricted nutrient availability. Under the SCFM condition, both models indicated
lower biomass production yields relative to unrestricted nutrient availability for uptake
and export, as would be expected when comparing a defined media where some
metabolites are limited or not provided. The Branco dos Santos et al. model indicated
generation of biomass with both formulations of SSM as the input media, but the Fyson
et al. model, which was tested previously with nutrients provided by charcoal agar,
suggested that biomass could not be synthesized on SSM. When single gene deletions
were simulated under the SCFM conditions, the Fyson et al. model predicted that 332
of the model’s 796 genes are essential for growth and the Branco dos Santos et al.
model predicted that 241 of the model’s 770 genes are essential for growth. The
model-predicted essential genes lists were each compared to genes found to be
experimentally essential in vivo in our Tn-seq analyses (Table S6).
We used the two GENREs to probe the function of Tn-seq-designated in vivo
essential genes associated with B. pertussis metabolism using SCFM as the input
medium. Based on Tn-seq analysis, two genes encoding products involved in glucose
metabolism were essential despite the fact that B. pertussis does not utilize glucose for
growth. At both 1 day and 3 days postinfection, BP3141 and BP3142, encoding a
Gonyar et al.
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phosphoglucomutase and a glucose-6-phosphate isomerase, respectively, were condi-
tionally essential. These enzymes facilitate the conversion of glucose to fructose-6-
phosphate, which can then enter either the glycolysis pathway or the pentose phos-
phate pathway (Fig. 3). Since glycolysis is not functional in B. pertussis, we hypothesized
that these enzymes were likely shuttling glucose into the pentose phosphate pathway.
When the genes were deleted in silico, model-simulated biomass production was
inhibited due to the inability to synthesize lipooligosaccharide (LOS) (Table S6). When
genes involved in the pentose phosphate pathway were deleted in silico, model-
simulated biomass production was similarly inhibited, but outputs derived from other
metabolic pathways in addition to LOS biosynthesis were affected as well (Table S6).
This result suggested that BP3141 and BP3142 were likely contributing to LOS biosyn-
thesis independently of the known LOS biosynthesis precursors generated by the
pentose phosphate pathway. In agreement with this finding, West et al. reported that
a strain lacking the homolog to BP3141 in the related organism Bordetella bronchisep-
tica was less able to survive in a murine model of respiratory infection and exhibited an
altered lipopolysaccharide (LPS) profile with no O antigen and a truncated core
oligosaccharide (39). Glucose is a component of the outer core Bordetella LOS, and we
next hypothesized that BP3141 and BP3142 are required for generation of glucose-1-
phosphate (glucose-1P) as a precursor for LOS outer core synthesis. To address this
hypothesis, we investigated whether the genes required for the addition of glucose to
the outer core were similarly required for in vivo fitness. A UDP-glucose:LOS-beta-1,4-
glucosyltransferase adds the first glucose residue to the HepI moiety of LOS. The gene
encoding this activity (BP2329) has been identified within a novel lipopolysaccharide
core biosynthesis gene cluster in B. pertussis (40). BP2329 is classified by our Tn-seq
analysis as conditionally essential in vivo, as well as the two other genes within this
locus that also result in a truncated LOS (BP2328 and BP2330) (40). Mutation of the
remaining gene within this operon, BP2331, did not result in a truncated LOS molecule
(40) and was not identified as conditionally essential in vivo in our analyses. Other genes
annotated as having a role in LOS biosynthesis that were assigned as conditionally
essential in vivo by Tn-seq were BP2325 and BP0388. BP2325 encodes a putative
UDP-glucose:heptosyl-alpha-1,3-glucosyltransferase which adds N-acetylglucosamine
(a derivative of glucose) to the HepII moiety. BP0388 is one of the few genes in the
major LOS pathway that was not essential in vitro, and it encodes phosphoheptose
isomerase, which incorporates sedoheptulose-7P into the LOS molecule. Cumulatively,
these results suggest a vital role of biosynthesis of full-length LOS in our in vivo model
and demonstrate how the GENREs aid in interpreting Tn-seq data.
Correlation of gene essentiality and single nucleotide polymorphism fre-
quency in human isolates of B. pertussis. By definition, mutations or variants in
essential genes of a genome are more likely than variants in nonessential genes to be
associated with a growth or fitness defect. We hypothesized that this concept would be
applicable to B. pertussis within its natural human host, and we tested whether data on
variation in individual genes from human isolates correlated with our gene essentiality
data determined by Tn-seq. For this comparison, we utilized the densities of single
nucleotide variants (SNVs) within genes from B. pertussis isolates as described previ-
ously (41). SNV densities were calculated based on a collection of 343 strains isolated
between 1920 and 2010 (41). The essential gene list derived from our data contained
the 609 genes that were designated essential by both TRANSIT and ARTIST analysis
(Table S2), and the nonessential list included the remaining 3015 genes encoded in the
Tohama genome. Based on analysis using an unpaired t test with Welch’s correction,
there were significantly fewer (P  0.0001) SNVs, both silent and nonsilent, in genes
that are essential in vitro (mean total SNV density of 0.0009588) versus genes that are
not essential in vitro (mean total SNV density of 0.001391).
Additionally, we hypothesized that genes that are essential in vivo would also be
associated with fewer SNVs in this data set than genes identified in vivo as nonessential.
Genes that are essential in vitro are unable to be assessed in vivo, and therefore, these
genes were excluded from this analysis. For in vivo essential genes identified by our
In Vivo Tn-seq in B. pertussis
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screen, we used 192 genes classified as conditionally essential at either day 1 or day 3
postinfection (Table S5) and compared SNV density in those genes to SNV density in
genes that are not essential in vivo (2,823 genes) using an unpaired t test with Welch’s
correction. There was no significant difference (P 0.0735) in the total SNV density
between essential genes (mean total SNV density of 0.001227) and nonessential genes
(mean total SNV density of 0.001402). Nonsilent SNVs are more likely to affect function
of a gene product and are therefore more similar to transposon insertion. In contrast to
the total SNV density comparison, there were fewer nonsilent SNVs in in vivo essential
genes (mean SNV density of 0.0006634) compared to nonessential genes (mean SNV
density of 0.0008771) (P 0.0023). Altogether, these findings suggest that Tn-seq-
derived gene essentiality presented in this study may correlate with gene variation
identified in clinical isolates, an interesting finding given the differences between the
method of Tn-seq and the nature of variation in the natural host.
DISCUSSION
This study describes the first in vivo Tn-seq analysis of B. pertussis, thus identifying
genes predicted to be necessary for wild-type levels of both in vitro and in vivo growth.
These data have been incorporated into two published metabolic models. One is a
method for exploring meaningful connections between essential genes, and the other
is aimed at improving understanding of essential gene function. We also incorporated
data from SNVs of clinical isolates, thus integrating our in vivo essentiality predictions
with data from human B. pertussis infections.
While many previous studies have investigated B. pertussis metabolism in order to
optimize growth in vitro, the resulting medium formulations likely do not reflect
nutrient availability in vivo. Because the evolution of B. pertussis has involved both
massive gene loss and a narrowing of its host range, we reasoned that its metabolic
activities might be especially tailored to the human respiratory tract and that as a result,
many of the genes involved might be critical for establishing infection in vivo. Addi-
tionally, the syntheses of some known virulence factors depend on intermediates
generated by central or secondary metabolic pathways, for example, lipopolysaccha-
rides, exopolysaccharides, siderophores, and quorum-sensing molecules (42). In this
sense, any gene that contributes to the fitness and survival of the pathogen may be
considered a virulence gene (43). Here, we use Tn-seq and metabolic modeling to
establish links between a known virulence factor, LOS, and its metabolic building
blocks.
B. pertussis does not grow on typical carbohydrates as the sole carbon source due
to an incomplete glycolysis pathway; three required genes (glucokinase, phosphofruc-
tokinase, and fructose-1,6-bis-phosphotase) are absent from the genome (7). However,
the pathway for gluconeogenesis is apparently fully functional. Our data show that this
pathway is essential, as transposon insertions in the genes encoding enzymes that
convert pyruvate to fructose-6P were underrepresented in in vitro growth conditions.
Our in vivo analysis also revealed that the genes interconverting fructose-6P and
glucose-1P, BP3141 and BP3142, were both essential at day 1 and at day 3 postinfection.
As glycolysis is not functional, we hypothesize that the selective advantage conferred
by this pathway is in the utilization of glucose to produce full-length lipo-
oligosaccharide, as glucose-1P is a component of the LOS outer core. Consistent with
this finding is the observation that a mutation in the homolog to BP3141 in B.
bronchiseptica resulted in an altered LPS profile, with no O antigen produced, a
truncated core oligosaccharide, and decreased survival in a murine model of respiratory
infection (39). This further supports the importance of the BP3142 phosphoglucomutase
in Bordetellae and suggests that the role of this enzyme in B. pertussis pathogenesis may
be in LOS biosynthesis during infection. Interpretation of these data was aided by in
silico analysis using GENREs and highlights the utility of these programs in interpreting
Tn-seq data sets. Our identification in this study of additional genes involved in the
production of mature, full-length LOS provides compelling evidence that this pathway
is crucial for B. pertussis survival in the murine respiratory tract.
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An unusual finding was the identification of the Bvg two-component system as
contributing to wild-type levels of in vitro growth under our culture conditions.
Mutations in bvgAS have been constructed in multiple B. pertussis strains, including a B.
pertussis UT25 ΔbvgAS strain generated in this study. This strain was able to be
generated and grown under the conditions used for the screen, which is validation that
these genes are not truly “essential.” However, we found that a B. pertussis UT25 ΔbvgAS
strain exhibited a growth defect in comparison to a wild-type parental strain, and this
growth defect is replicated by chemical modulation to a Bvg inactive state with MgSO4.
We speculate that this growth defect was likely further exacerbated under competitive
growth conditions in a pool of clones possessing wild-type bvgAS alleles. Other
potential explanations for this finding include the potential for functionally or struc-
turally guarded genes that do not permit transposon insertion in Bvg such as extensive
binding proteins or a three-dimensional structure of the gene (44). Although the
finding with bvgAS serves as evidence that some of the genes identified in our screen,
more likely through the hidden Markov model analyses than the more stringent
analyses, are not true essential genes, these genes contribute to efficient growth under
our conditions and therefore are important for exploration.
We asked whether essential genes identified by Tn-seq predict which genes in B.
pertussis are subject to variation and tested this question by comparing in vivo
Tn-seq-based gene essentiality to SNVs identified in 343 strains of B. pertussis collected
between 1920 and 2010 (41). We found that in vitro essential genes had a lower total
and nonsilent SNV density than in vitro nonessential genes. Genes that were condi-
tionally essential in vivo also had a lower nonsilent SNV density than genes that were
not essential in vivo. These data suggest that genes identified in the in vitro and in vivo
studies as essential are associated with gene variation identified in clinical isolates from
human infection.
There are caveats to this suggestion that the comparison of in vivo essential genes
to SNV data supports a connection of the Tn-seq essentiality assignments to human
infection. The screen was performed in an intranasal murine infection model, which
differs from human infection with B. pertussis and does not replicate the clinical features
of pertussis. The method of inoculation and burden of infection may result in different
selective pressure due to anatomy, nutrient availability, and different inflammatory
responses among other aspects. The early time points of the Tn-seq in vivo studies likely
include different selective pressures than those to which human isolates are subjected
in the first several weeks of human infection prior to cultures being obtained. None-
theless, we expect that some of the selective pressures and growth requirements in
humans and mice over these differing times are comparable, particularly in the case of
metabolic genes included in the Tn-seq data set. In fact, the abundance of metabolic
genes favors the association between Tn-seq and SNV analysis, as virulence factors vary
more than nonvirulence factors (45).
In addition to host- and infection-related differences between Tn-seq data and SNV
data, there are fundamental methodologic differences between these data. In Tn-seq,
a complex library of clones containing unique insertions located across the genome is
created simultaneously in a single isolate and then subjected to pressure. The forward
introduction of variation is therefore presumed to be equal across the genome except
for experimental biases introduced by the transposon’s (e.g., TA site preference) ability
to insert into structurally guarded genes (e.g., protein binding regions or H-NS regions
[44]) and the in vitro conditions under which the library was generated. It is essentially
also comprehensive, if saturating Tn mutagenesis is performed. SNVs, on the other
hand, accumulate over time, both randomly and in response to host selection, their
introduction is far from comprehensive, and their detection is limited by the degree of
sampling of the genome, allelic frequency, and number of samples interrogated (46,
47). The effects of SNVs, with the exception of nonsense and frameshift mutations, on
gene function will be impossible to predict in the vast majority of cases. Transposon
insertion into a gene, on the other hand, will usually disrupt gene function.
Presumably, increased time of the Tn-seq pool within the host will subject it to
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prolonged and/or additional pressures, which may alter the spectrum of genes iden-
tified as essential in vivo. Balancing this, prolonged residence in the host may result in
fewer bacteria recovered, resulting in loss of diversity in the Tn-seq output pool, due to
random loss of subpopulations stochastically. Robust sequencing and analysis require
sufficient numbers of bacteria in order to maintain statistical and analytical power. With
a smaller number of bacteria recovered, the number of replicates would have to be
increased substantially for statistical power. Therefore, the time point of 3 days, which
is at or near the peak of bacterial burden (25) was chosen. Bacteria recovered from the
host at day 1 postinfection have been subjected to limited host pressure, and output
pool analysis at this earlier time point could logically be expected to show fewer
essential genes than at day 3 postinfection. Furthermore, analysis of day 1 or day 3
output pools is expected to be more indicative of early growth requirements in the host
and/or of selective pressures from innate, rather than adaptive, immune mechanisms.
Future studies will be required to assess selective pressures experienced at later time
points and may be challenging due to decreased bacterial recovery.
In this study, we generated a diverse library of transposon mutants and used this
library to probe gene essentiality in vivo in a murine model of intranasal infection. This
screen generated a large data set that will be a valuable resource for future investiga-
tions into B. pertussis pathogenesis to support the design of improved vaccines. It also
enabled novel observations about metabolism and gene regulation in vitro and in vivo.
Integration of these data with other published reports and available metabolic models
provided a more comprehensive understanding of metabolism and gene essentiality in
this pathogen that has undergone genome condensation and reduction of its host
range during its evolution. Understanding B. pertussismetabolism and gene essentiality
in vivo may also be used to direct the design of growth media that more accurately
reflect in vivo growth and that may therefore enable identification of new vaccine
antigen candidates.
MATERIALS AND METHODS
Additional methods are included in Text S1 in the supplemental material.
Ethics statement. All animal work was approved by the University of Virginia Institutional Animal
Care and Use Committee protocol 4004.
Construction of library. B. pertussis strain UT25-lux (Text S1) was grown as indicated on BG and then
passaged into SSM for growth for 20 to 24 h at 35.5°C shaking. The culture was diluted to an optical
density at 600 nm (OD600) of 0.08 and grown for 18 to 20 h to an OD600 of 0.7 to 0.8. E. coli strain RHO3
(15) was grown shaking at 35.5°C for 16 to 18 h in the presence of DAP. Cultures of B. pertussis and E. coli
were washed to remove antibiotics, combined in SSM (50 to 100 l), and incubated statically on
BGMgSO4DAP for 18 to 24 h at 37°C. The mixed mating was then harvested, washed once, and plated
on BGkanamycin in the absence of DAP. Colonies were visible after 3 days of growth at 37°C.
Transposon insertion was verified by positive PCR for the kanamycin cassette and negative PCR for the
pSAM backbone, suggesting integration of the transposon into chromosomal DNA and loss of the
pSAM-Km plasmid. Southern blot analysis indicated that most clones had a single insertion site.
In vitro and in vivo screening of library. For preparation of bacterial inocula, 1 108 CFU of library
was plated on four large plates, grown for 3 days on BGKan, collected, washed, and replated on fresh
BG for 2 days. The colonies were harvested by swabbing, washed, and diluted to obtain the desired dose.
Four-week-old CD1 mice (Charles River) were infected intranasally with 20 l of PBS containing approx-
imately 5 106 CFU. Genomic DNA from the remainder of the inoculum was prepared and used as the
input sample for comparative analysis and the BG-grown sample for in vitro analysis. Mice were
euthanized at day 1 (n 11) or day 3 (n 12), and lungs and trachea were extracted, weighed, pooled,
and homogenized. Organ homogenates were serially diluted and plated to determine bacterial load; the
remainder of the homogenized sample was plated on BG, grown for 2 days, and collected for preparation
of genomic DNA. Genomic DNA was prepared following the manufacturer’s instructions (Wizard genomic
DNA purification kit; Promega).
Accession number(s). The mapped reads are available at the Sequence Read Archive (SRA) under
BioProject accession number PRJNA542053 and SRA accession number SRP197242.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mSphere.00694-18.
TEXT S1, DOCX file, 0.04 MB.
FIG S1, TIF file, 2.5 MB.
FIG S2, TIF file, 0.4 MB.
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TABLE S1, XLSX file, 0.01 MB.
TABLE S2, XLSX file, 0.05 MB.
TABLE S3, XLSX file, 0.03 MB.
TABLE S4, XLSX file, 0.6 MB.
TABLE S5, XLSX file, 0.03 MB.
TABLE S6, XLSX file, 0.03 MB.
TABLE S7, XLSX file, 0.01 MB.
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